Children living in the same household with adults who work in mineral dust-releasing jobs may have an increased risk of…
Articles by Marta Figueiredo, PhD
The blood levels of natural killer T-cells (NKT), a type of immune cell, are reduced significantly in sarcoidosis patients…
The U.S. Food and Drug Administration has granted orphan drug designation to aTyr Pharma’s experimental immunomodulatory molecule ATYR1923 for the treatment…
White women with sarcoidosis and multiorgan involvement may be at a higher risk of hypothyroidism, or low thyroid…
aTyr Pharma’s experimental therapy ATYR1923 safely and effectively improves lung function and reduces symptoms in adults with…
The U.S. Food and Drug Administration has granted orphan drug designation to RLF-100 (aviptadil), Relief Therapeutics’ investigational inhaled therapy…
The use of Acthar Gel (repository corticotropin injection, or RCI) was among medications noted by both European and U.S. panels…
The U.S. Food and Drug Administration (FDA) has approved beginning clinical trials testing XTMAB-16, Xentria’s investigational TNF-alpha inhibitor for…
The Foundation for Sarcoidosis Research (FSR) is holding a two-day virtual patient education summit focused on providing relevant medical content…
aTyr Pharma, which is developing a candidate therapy for pulmonary sarcoidosis called ATYR1923, has appointed Andrea Wilson — a…